infliximab,vedolizumab
takeda,janssen
['psoriasis', 'avsola', 'axspa', 'psoriatic arthritis', 'remicade', 'vedo', 'rheumatoid,arthritis', 'delta i,(-delta ii)', ' psa', ' vedo', 'vedolizumab', ' uc ']
biosimilars should be embraced as they are safe as efficacious as originator and we have robust data. plus 54 billion dolar saving expected in the us with 10 years biosimilar use!!! #ddw2023 #agalive2023 
Celebrate life. Gastroenterologist #IBD passionate. Help others grow their abilities. https://t.co/4V0xhhdIti